Sunday, November 22, 2015

Ayurveda Medicine for Type 2 Diabetes - Scientifically Validated

Now a days after Ramdev Baba, started manufacturing the Ayurveda medicines for various ailments, slowly Ayurveda is finding place as reliable medicine for cure.

As a result,A scientifically validated anti-diabetes herbal drug, named 'BGR-34', was launched by a Council of Scientific and Industrial Research (CSIR) lab, in India. A combination of natural extracts from plants, the drug is based on Ayurveda and has no side effects. The drug is for management of type-II diabetes mellitus.

The drug has been jointly developed by two CSIR laboratories, National Botanical Research Institute (NBRI) and Central Institute for Medicinal and Aromatic Plant (CIMAP). The drug has extracts from four plants mentioned in Ayurveda and that makes it safe. It has been tested on animals and scientific study has found it safe and effective, with clinical trials showing 67% success.


The drug boosts immune system, works as antioxidant and checks free radicals. Though there are other anti-diabetes herbal drugs in the market, 'BGR-34' has been validated scientifically and will cost Rs 5 per pill. The drug will help maintain normal blood glucose levels, reduce chances of complications due to persistent high blood glucose levels and impart a good quality life to patients with high blood sugar levels.

BGR-34 EXCLUSIVE BENEFITS : Scientifically proven, clinically and toxicologically tested with exclusive benefits
- Potential DDP-4 inhibitor with cardio protective action
- Scientifically proven, optimized formulation
- Enriched with 34 vital phytocontituents, derivatives
- Regulates glucose homeostasis
- Converts proinsulin to insulin
- Reduces level of glycosylated Hb
- Exerts anti-oxidant action.

Still do not whether it will be used as mainstream medicine for diabetes similar to other osteopathy medicines. A word caution, before taking the medicine take advice from your physicians or dermatologist or doctors.

It is now available online from AyurvedaMart.